Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2005
12/08/2005US20050271750 Topical formulation for prevention and treatment of acne
12/08/2005US20050271743 Treatment of inflammatory skin conditions
12/08/2005US20050271624 Use of apoptosis inducing agents in the treatment of (auto) immune diseases
12/08/2005US20050271606 Composition for treating inflammation which contains zinc pyrrolidonecarboxylate
12/08/2005US20050271604 Matrix protein compositions for wound healing
12/08/2005US20050269546 Valve with a two-component seal
12/08/2005CA2568766A1 Crth2 receptor ligands for medicinal uses
12/08/2005CA2568409A1 A chronic joint inflammation-modulating composition made of collagen-polyvinylpyrrolidone
12/08/2005CA2566863A1 Purine derivative
12/08/2005CA2565805A1 Msh-agonist tripeptide conjugates
12/08/2005CA2563466A1 Anti-cytokine heterocyclic compounds
12/07/2005EP1602660A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602655A1 Benzofuran derivative
12/07/2005EP1602647A1 Novel compound having 4-pyridylalkylthio group as substituent
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1601677A1 Spiro-substituted pyrrolopyrimidines
12/07/2005EP1601673A1 Novel fused heterocycles and uses thereof
12/07/2005EP1601672A1 Triazolo-pyridines as anti-inflammatory compounds
12/07/2005EP1601665A2 Urea derivatives
12/07/2005EP1601663A1 Nitrate esters of phenylaminothiophenacetic acid derivatives
12/07/2005EP1601656A1 Tetrahydroquinoline derivatives useful as serine protease inhibitors
12/07/2005EP1601644A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
12/07/2005EP1601374A2 Compositions and methods for diagnosing and treating an inflammation
12/07/2005EP1601350A1 Titration dosing regimen for controlled release tramadol
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1458715B1 Novel compounds
12/07/2005EP1425381A4 Emu-based formulations for wound treatment related application information
12/07/2005EP1423409A4 Gastrokines and derived peptides including inhibitors
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1322305B1 Use of r-arylpropionic acids for producing medicaments for treating illnesses with a rheumatic nature
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1263978B1 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1155019B1 Substituted porphyrins and their therapeutic use
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1011658B1 Analgesic compositions comprising anti-epileptic compounds and methods of using same
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005CN1705650A Isothiazole derivatives, process for the preparation thereof, and pharmaceutical composition including the same
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1705645A Methylene urea derivatives as raf-kinase inhibitors
12/07/2005CN1705470A Dosage form of sodium ibuprofen
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230536C Tie-2 ligands, methods of making and uses thereof
12/07/2005CN1230441C Integrin binding peptide derivatives
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230421C Amide compounds and medicinal use thereof
12/07/2005CN1230202C External coated chewing gum products
12/07/2005CN1230172C Blood circulation improving agent
12/07/2005CN1230167C Dual-release compositions of cyclooxygenase-2-inhibitor
12/07/2005CN1230156C Fibrauretine dispersant tablet and its preparing method
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972290 Piperazine derivatives and their use as anti-inflammatory agents
12/06/2005CA2347512C Adenine derivatives
12/06/2005CA2303244C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
12/06/2005CA2303177C Taste masked pharmaceutical compositions
12/06/2005CA2268866C Substituted arylalkylamines as neurokinin antagonists
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/06/2005CA2129527C Pharmaceutical composition usable as an analgesic, comprising (r)-(benzoyl-3-phenyl)-2-propionic acid
12/02/2005CA2509077A1 Water-based compositions comprising a polyethylene glycol-based solubilizing agent and a taxane useful in the treatment of coronary artery disease
12/01/2005WO2005113569A1 Novel 3-triazolyl-galactoside inhibitors of galectins
12/01/2005WO2005113568A1 Novel galactoside inhibitors of galectins
12/01/2005WO2005113534A2 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005WO2005113501A1 Neurogenic pain control agent composition
12/01/2005WO2005113499A1 Indole compounds
12/01/2005WO2005112965A2 Botanical anti-inflammatory compositions and methods
12/01/2005WO2005112909A1 Anti-inflammatory analgesic external aqueous liquid preparation
12/01/2005WO2004071384A3 New pharmaceutical compositions based on anticholinergics and tace-inhibitors
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267205 2,4-dihydroxybenzoic acid derivatives
12/01/2005US20050267204 Synergistic gold-containing compositions
12/01/2005US20050267196 Reducing tumor necrosis factor; phosphodiesterase inhibitor; anticancer agents; antidepressants; antiinflammatory agents; skin dsorders; antidepressants
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267165 Il-8 receptor antagonists
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267137 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
12/01/2005US20050267129 Dipeptide nitrile cathepsin K inhibitors
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
12/01/2005US20050267113 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; interleu
12/01/2005US20050267062 Endothelial growth factors; antiischemic agents; neovascularization
12/01/2005US20050267035 Peptide and polypeptide inhibitors of complement C1s
12/01/2005US20050267024 Polypeptide, cancer therapy, neovascularization defects, retinopathies, arthritis and psoraisis
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266108 Methods of purifying cannabinoids from plant material
12/01/2005US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies
12/01/2005US20050265987 Sulfatases and methods of use thereof
12/01/2005CA2826538A1 3-triazolyl-galactoside inhibitors of galectins
12/01/2005CA2567700A1 3-triazolyl-galactoside inhibitors of galectins
12/01/2005CA2567694A1 Novel galactoside inhibitors of galectins
1 ... 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 ... 1272